로고

LUCASBIO - 루카스바이오
HOME 문의하기
  • Clinical Trials
  • Clinical Trials

    루카스바이오의 임상시험현황을 알려드립니다.

    Clinical Trials 목록
    연구제목 세포종류 IIT/SIT 단계 목표대상자수 CRIS 등록번호 현황
    An investigator's initiated trial to evaluate the safety of cytokine-induced killers during early transplant period of autologous hematopoeitic stem cell transplant recipients
    세포종류 : Immune cell
    IIT/SIT : IIT
    단계 : I/II
    목표대상자수 : 32
    CRIS 등록번호 : KCT0004024
    Immune cell IIT I/II 32 KCT0004024
    Pilot study of bone marrow-derived mesenchymal stem cells for the treatment of refractory hemorrhagic cystitis occurring after hematopoietic stem cell transplantation
    ss
    세포종류 : Stem cell
    IIT/SIT : IIT
    단계 : I
    목표대상자수 : 3
    CRIS 등록번호 : KCT0002826
    Stem cell IIT I 3 KCT0002826
    A phase I study to evaluate the safety of four repeated infusions of bone marrow-derived mesenchymal stem cells for the treatment of steroid-refractory and progressive chronic graft-versus host disease
    A phase I study to evaluate the safety of four repeated infusions of bone marrow-derived mesenchymal stem cells for the treatment of steroid-refractory and progressive chronic graft-versus host disease
    세포종류 : Stem cell
    IIT/SIT : IIT
    단계 : I
    목표대상자수 : 10
    CRIS 등록번호 : KCT0001894
    Stem cell IIT I 10 KCT0001894
    The safety and efficacy of EBV specific cytotoxic T cell in patients with EBV positive post-transplant lymphoproliferative disease
    The safety and efficacy of EBV specific cytotoxic T cell in patients with EBV positive post-transplant lymphoproliferative disease
    세포종류 : Immune cell
    IIT/SIT : IIT
    단계 : I
    목표대상자수 : 3
    CRIS 등록번호 : KCT0001996
    Immune cell IIT I 3 KCT0001996
    Safety and efficacy of administration of EBV specific cytotoxic T lymphocytes in chemotherapy responding EBV positive NK/T cell lymphoma patients.
    Safety and efficacy of administration of EBV specific cytotoxic T lymphocytes in chemotherapy responding EBV positive NK/T cell lymphoma patients.
    세포종류 : Immune cell
    IIT/SIT : IIT
    단계 : I/II
    목표대상자수 : 11
    CRIS 등록번호 : KCT0001271
    Immune cell IIT I/II 11 KCT0001271

    SEARCH

    고객센터
    LUCASBIO
    주소 : 서울시 서초구 반포대로 222 서울성모병원 (반포동 505) ㅣ 대표전화 : 02-532-2520 ㅣ Fax : 02-534-2520
    주소 : 서울시 서초구 반포대로 222 서울성모병원 (반포동 505)
    대표전화 : 02-532-2520 ㅣ Fax : 02-534-2520